Radio and PodcastRadio and PodcastLive Radio & Podcasts
Nusinersen for Spinal Muscular Atrophy: Ensuring Equity at High Cost artwork
Health

Nusinersen for Spinal Muscular Atrophy: Ensuring Equity at High Cost

JAMA Pediatrics Author Interviews: Covering research, science, & clinical practice in the health and well-being of infants, children, and adolescents by American Medical Association

Dec 11, 201720:50Health

Interview with Alyssa Burgart, MD, MA, author of Ethical Challenges Confronted When Providing Nusinersen Treatment for Spinal Muscular Atrophy , and Vinay Prasad, author of Nusinersen for Spinal Muscular Atrophy: Are We...

About This Episode

Nusinersen for Spinal Muscular Atrophy: Ensuring Equity at High Cost is an episode from JAMA Pediatrics Author Interviews: Covering research, science, & clinical practice in the health and well-being of infants, children, and adolescents by...

Podcast

This episode belongs to JAMA Pediatrics Author Interviews: Covering research, science, & clinical practice in the health and well-being of infants, children, and adolescents.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Dec 11, 2017, 20:50 long, audio available.

Related Episodes

Continue listening to more episodes from JAMA Pediatrics Author Interviews: Covering research, science, & clinical practice in the health and well-being of infants, children, and adolescents.

Questions About This Episode

What is Nusinersen for Spinal Muscular Atrophy: Ensuring Equity at High Cost about?

Interview with Alyssa Burgart, MD, MA, author of Ethical Challenges Confronted When Providing Nusinersen Treatment for Spinal Muscular Atrophy , and Vinay Prasad, author of Nusinersen for Spinal Muscular Atrophy: Are We Paying Too Much for Too Little?

Where can I listen to Nusinersen for Spinal Muscular Atrophy: Ensuring Equity at High Cost?

You can listen to Nusinersen for Spinal Muscular Atrophy: Ensuring Equity at High Cost online on Radio and Podcast. Open the player on this page to stream the available audio.

Which podcast is Nusinersen for Spinal Muscular Atrophy: Ensuring Equity at High Cost from?

Nusinersen for Spinal Muscular Atrophy: Ensuring Equity at High Cost is an episode from JAMA Pediatrics Author Interviews: Covering research, science, & clinical practice in the health and well-being of infants, children, and adolescents by American Medical Association.

How long is this episode?

This episode is 20:50 long.

When was this episode published?

This episode was published on Dec 11, 2017.

Can I save Nusinersen for Spinal Muscular Atrophy: Ensuring Equity at High Cost for later?

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Are there related episodes from JAMA Pediatrics Author Interviews: Covering research, science, & clinical practice in the health and well-being of infants, children, and adolescents?

Yes. This page shows related episodes from JAMA Pediatrics Author Interviews: Covering research, science, & clinical practice in the health and well-being of infants, children, and adolescents when more episodes are available from the podcast feed.

Quick Answers About This Episode

Where can I listen to Nusinersen for Spinal Muscular Atrophy: Ensuring Equity at High Cost?

You can listen to Nusinersen for Spinal Muscular Atrophy: Ensuring Equity at High Cost on this page when the episode audio is available from the podcast feed.

Which podcast is this episode from?

Nusinersen for Spinal Muscular Atrophy: Ensuring Equity at High Cost is from JAMA Pediatrics Author Interviews: Covering research, science, & clinical practice in the health and well-being of infants, children, and adolescents by American Medical Association.

What are the episode details?

Published Dec 11, 2017 and 20:50 long